Flumazenil-Baxter flumazenil 1 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

flumazenil-baxter flumazenil 1 mg/10 ml solution for injection ampoule

baxter healthcare pty ltd - flumazenil, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; water for injections; sodium hydroxide; glacial acetic acid - flumazenil-baxter is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil-claris. not to be used in outpatients or short stay patients. not to be used as a diagnostic.

Flumazenil-Baxter flumazenil 0.5 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

flumazenil-baxter flumazenil 0.5 mg/5 ml solution for injection ampoule

baxter healthcare pty ltd - flumazenil, quantity: 0.5 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide; disodium edetate; glacial acetic acid; sodium chloride - flumazenil-baxter is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil-claris. not to be used in outpatients or short stay patients. not to be used as a diagnostic.

Potassium Chloride 30mmol in 4% Glucose and 0.18% Sodium Chloride (Baxter) New Zealand - English - Medsafe (Medicines Safety Authority)

potassium chloride 30mmol in 4% glucose and 0.18% sodium chloride (baxter)

baxter healthcare ltd - glucose 40 g/l; potassium chloride 2.24 g/l; sodium chloride 1.8 g/l - solution for infusion - 30 mmol/l - active: glucose 40 g/l potassium chloride 2.24 g/l sodium chloride 1.8 g/l - for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

BAXTER AHB8611 ELECTROLYTE SOLUTION COMPOUND SODIUM LACTATE (HARTMANN'S SOLUTION) 5000ML Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

baxter ahb8611 electrolyte solution compound sodium lactate (hartmann's solution) 5000ml

baxter healthcare pty ltd - calcium chloride; potassium chloride; sodium lactate; sodium chloride - parenteral liquid/solution/suspension - calcium chloride mineral-calcium-salt active 0.27 g/l; potassium chloride mineral-potassium active 0.4 g/l; sodium lactate mineral-sodium active 3.22 g/l; sodium chloride mineral-sodium-salt active 6.0 g/l - nutrition & metabolism - all animals - dehydration | electrolyte replacement

Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.45% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6024) Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.45% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6024)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.9% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6066) Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.9% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6066)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 9 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 1000mL bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose intravenous infusion glucose 1000ml bag

baxter healthcare pty ltd - glucose, quantity: 45 g (equivalent: glucose monohydrate, qty 50 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 500mL bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose intravenous infusion glucose 500ml bag

baxter healthcare pty ltd - glucose, quantity: 22.5 g (equivalent: glucose monohydrate, qty 25 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 250mL bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose intravenous infusion glucose 250ml bag

baxter healthcare pty ltd - glucose, quantity: 11.25 g (equivalent: glucose monohydrate, qty 12.5 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

BAXTER SEVOFLURANE sevoflurane 250mL inhalation liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

baxter sevoflurane sevoflurane 250ml inhalation liquid bottle

baxter healthcare pty ltd - sevoflurane, quantity: 250 ml - inhalation - excipient ingredients: - for induction and maintenance of general anaesthesia in adults and paediatric patients undergoing surgery.